RC88 Treatment for Platinum-Resistant Ovarian Cancer with Liver/Bone/Lymph Node Metastases: A Case Report
AI Summary The patient had platinum-resistant ovarian cancer with multiple treatment failures, presenting with liver, lymph node, and bone metastases, and conventional treatments were ineffective. After using the novel targeted drug RC88, significant shrinkage of liver metastases and hilar lymph nodes was observed, with a reduction in the extent of bone metastases, achieving partial remission. … Read more